Connor Clark & Lunn Investment Management Ltd. acquired a new stake in National HealthCare Corporation (NYSEAMERICAN:NHC - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 6,672 shares of the company's stock, valued at approximately $1,410,000.
Several other institutional investors have also added to or reduced their stakes in NHC. Strs Ohio purchased a new stake in shares of National HealthCare during the fourth quarter valued at $809,000. Militia Capital Management LLC bought a new position in shares of National HealthCare during the 1st quarter valued at $2,827,000. Morgan Stanley Institutional Investment Advisors LLC increased its holdings in National HealthCare by 38.6% during the fourth quarter. Morgan Stanley Institutional Investment Advisors LLC now owns 1,038,787 shares of the company's stock valued at $142,407,000 after buying an additional 289,566 shares during the last quarter. BlackRock Inc. purchased a new position in National HealthCare during the second quarter valued at $417,602,000. Finally, First Trust Advisors LP grew its stake in shares of National HealthCare by 45.4% during the 1st quarter. First Trust Advisors LP now owns 530,302 shares of the company's stock valued at $84,689,000 after acquiring an additional 165,615 shares during the period. 56.44% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at National HealthCare
In other news, CEO Stephen Fowler Flatt sold 1,500 shares of the stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $237.08, for a total transaction of $355,620.00. Following the completion of the transaction, the chief executive officer directly owned 65,487 shares in the company, valued at approximately $15,525,657.96. This represents a 2.24% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director David R. Gifford sold 1,779 shares of the firm's stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $225.42, for a total transaction of $401,022.18. Following the completion of the transaction, the director directly owned 1,030 shares of the company's stock, valued at approximately $232,182.60. This trade represents a 63.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 13.92% of the company's stock.
National HealthCare Stock Performance
NHC stock opened at $222.70 on Friday. The company's fifty day moving average price is $219.36 and its 200-day moving average price is $189.89. National HealthCare Corporation has a one year low of $111.24 and a one year high of $239.29. The company has a market capitalization of $3.49 billion, a PE ratio of 25.05 and a beta of 0.61.
National HealthCare (NYSEAMERICAN:NHC - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $1.74 earnings per share for the quarter. The company had revenue of $408.03 million during the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%.
National HealthCare Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 30th. National HealthCare's payout ratio is 61.89%.
Analyst Ratings Changes
A number of research analysts recently weighed in on NHC shares. BMO Capital Markets upgraded shares of National HealthCare to a "hold" rating in a research note on Monday, May 18th. Royal Bank Of Canada raised National HealthCare to a "hold" rating in a report on Monday, May 18th. The Goldman Sachs Group upgraded National HealthCare to a "strong-buy" rating in a research report on Monday, May 18th. Finally, Robert W. Baird upgraded National HealthCare to a "strong-buy" rating in a research report on Monday, May 18th. Two investment analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Buy".
Check Out Our Latest Stock Analysis on NHC
National HealthCare Profile
(
Free Report)
National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.
Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider National HealthCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National HealthCare wasn't on the list.
While National HealthCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
